Jon Berggren
Stock Analyst at Kepler Capital
(4.26)
# 1,434
Out of 4,698 analysts
72
Total ratings
61.1%
Success rate
18.2%
Average return
Main Sectors:
Stocks Rated by Jon Berggren
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: 0MGB Genmab A/S | Maintained: Hold | kr 2,100 | kr 2,197 | -4.42% | 4 | May 7, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Buy | kr 350.00 | kr 460.00 | -23.91% | 14 | Apr 29, 2026 | |
| STO: DYVOX Dynavox Group AB (publ) | Maintained: Hold | kr 125.00 → kr 90.00 | kr 77.85 | +15.61% | 7 | Apr 27, 2026 | |
| FRA: 7XE Nightingale Health Oyj | Maintained: Sell | €1.00 | €0.79 | n/a | 3 | Mar 27, 2025 | |
| AIM: FARN Faron Pharmaceuticals Oy | Maintained: Sell | 77p → 69p | 38p | n/a | 4 | Feb 28, 2025 | |
| FRA: 4YL Nanoform Finland Oyj | Maintained: Buy | €3.00 | €0.93 | n/a | 3 | Feb 27, 2025 | |
| LON: 0KFH Revenio Group Oyj | Maintained: Sell | €26.00 | €16.02 | n/a | 5 | Feb 14, 2025 | |
| STO: BACTI.B Bactiguard Holding AB (publ) | Maintained: Hold | kr 35.00 → kr 30.00 | kr 16.30 | n/a | 4 | Feb 7, 2025 | |
| HUM Humana | Maintained: Hold | $2.61 | $406.52 | n/a | 1 | Apr 4, 2024 | |
| STO: HUM Humana AB (publ) | Maintained: Hold | kr 25.00 | kr 70.20 | n/a | 14 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $1.76 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €135.00 | €75.95 | n/a | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €172.00 | €76.76 | n/a | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 640.00 | CHF 195.60 | n/a | 1 | Jan 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €42.00 | €4.03 | n/a | 2 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €155.00 | €13.07 | n/a | 2 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €105.00 | €76.27 | n/a | 1 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 9,200p | 12,146p | n/a | 1 | Dec 17, 2020 |
Genmab A/S
May 7, 2026
Maintained: Hold
Price Target: kr 2,100
Current: kr 2,197
Upside: -4.42%
Swedish Orphan Biovitrum AB (publ)
Apr 29, 2026
Maintained: Buy
Price Target: kr 350.00
Current: kr 460.00
Upside: -23.91%
Dynavox Group AB (publ)
Apr 27, 2026
Maintained: Hold
Price Target: kr 125.00 → kr 90.00
Current: kr 77.85
Upside: +15.61%
Nightingale Health Oyj
Mar 27, 2025
Maintained: Sell
Price Target: €1.00
Current: €0.79
Upside: n/a
Faron Pharmaceuticals Oy
Feb 28, 2025
Maintained: Sell
Price Target: 77p → 69p
Current: 38p
Upside: n/a
Nanoform Finland Oyj
Feb 27, 2025
Maintained: Buy
Price Target: €3.00
Current: €0.93
Upside: n/a
Revenio Group Oyj
Feb 14, 2025
Maintained: Sell
Price Target: €26.00
Current: €16.02
Upside: n/a
Bactiguard Holding AB (publ)
Feb 7, 2025
Maintained: Hold
Price Target: kr 35.00 → kr 30.00
Current: kr 16.30
Upside: n/a
Humana
Apr 4, 2024
Maintained: Hold
Price Target: $2.61
Current: $406.52
Upside: n/a
Humana AB (publ)
Apr 4, 2024
Maintained: Hold
Price Target: kr 25.00
Current: kr 70.20
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $22
Current: $1.76
Upside: n/a
Jan 20, 2022
Maintained: Buy
Price Target: €135.00
Current: €75.95
Upside: n/a
Jan 20, 2022
Maintained: Hold
Price Target: €172.00
Current: €76.76
Upside: n/a
Jan 20, 2022
Maintained: Buy
Price Target: CHF 640.00
Current: CHF 195.60
Upside: n/a
Nov 29, 2021
Maintained: Buy
Price Target: €42.00
Current: €4.03
Upside: n/a
Nov 29, 2021
Maintained: Buy
Price Target: €155.00
Current: €13.07
Upside: n/a
Jun 29, 2021
Maintained: Buy
Price Target: €105.00
Current: €76.27
Upside: n/a
Dec 17, 2020
Maintained: Buy
Price Target: 9,200p
Current: 12,146p
Upside: n/a